

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.62005001 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62005001 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.28468166 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28468166 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.50543617 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.83542039 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.82304483 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.61445090 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.61445090 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.61445090 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.54989557 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.46574728 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.39070288 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 5.33225996 |
| 15 | proline metabolic process (GO:0006560) | 5.31226486 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.23871462 |
| 17 | cysteine metabolic process (GO:0006534) | 5.19519823 |
| 18 | proline biosynthetic process (GO:0006561) | 5.17738873 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.02920744 |
| 20 | urea metabolic process (GO:0019627) | 4.89952516 |
| 21 | urea cycle (GO:0000050) | 4.89952516 |
| 22 | bile acid metabolic process (GO:0008206) | 4.87407918 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 4.77125820 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 4.73924476 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.71808270 |
| 26 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.71737845 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.65840434 |
| 28 | protein carboxylation (GO:0018214) | 4.63755729 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.63755729 |
| 30 | regulation of fibrinolysis (GO:0051917) | 4.63022070 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 4.54748479 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.51640355 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.49605038 |
| 34 | complement activation, alternative pathway (GO:0006957) | 4.48555421 |
| 35 | coenzyme catabolic process (GO:0009109) | 4.48044660 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.47933685 |
| 37 | triglyceride homeostasis (GO:0070328) | 4.46153819 |
| 38 | acylglycerol homeostasis (GO:0055090) | 4.46153819 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.45503259 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.39933535 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 4.35914665 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.33677255 |
| 43 | heme transport (GO:0015886) | 4.27394364 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.26452146 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.26452146 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.26452146 |
| 47 | acetyl-CoA metabolic process (GO:0006084) | 4.26444676 |
| 48 | cholesterol efflux (GO:0033344) | 4.23350142 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.22913170 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.22913170 |
| 51 | serine family amino acid biosynthetic process (GO:0009070) | 4.22040262 |
| 52 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.21458165 |
| 53 | regulation of plasminogen activation (GO:0010755) | 4.19760234 |
| 54 | homocysteine metabolic process (GO:0050667) | 4.18575615 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 4.18365187 |
| 56 | regulation of complement activation (GO:0030449) | 4.16605026 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 4.15290397 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.12121096 |
| 59 | phospholipid efflux (GO:0033700) | 4.12115341 |
| 60 | fatty acid elongation (GO:0030497) | 4.11121793 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.10172206 |
| 62 | ethanol oxidation (GO:0006069) | 4.09954471 |
| 63 | glycine metabolic process (GO:0006544) | 4.09467610 |
| 64 | glutamate metabolic process (GO:0006536) | 4.08173584 |
| 65 | lysine catabolic process (GO:0006554) | 4.05628491 |
| 66 | lysine metabolic process (GO:0006553) | 4.05628491 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.04002914 |
| 68 | amine catabolic process (GO:0009310) | 4.04002914 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.01641954 |
| 70 | NADH metabolic process (GO:0006734) | 4.00999826 |
| 71 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.00322725 |
| 72 | plasma lipoprotein particle assembly (GO:0034377) | 3.96615841 |
| 73 | regulation of cholesterol homeostasis (GO:2000188) | 3.93879846 |
| 74 | low-density lipoprotein particle clearance (GO:0034383) | 3.90592716 |
| 75 | bile acid and bile salt transport (GO:0015721) | 3.87665295 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 3.87142541 |
| 77 | regulation of apoptotic cell clearance (GO:2000425) | 3.86716776 |
| 78 | intestinal cholesterol absorption (GO:0030299) | 3.86169144 |
| 79 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86103051 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86103051 |
| 81 | regulation of bile acid biosynthetic process (GO:0070857) | 3.84937209 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 3.82901060 |
| 83 | cofactor catabolic process (GO:0051187) | 3.82862007 |
| 84 | aldehyde catabolic process (GO:0046185) | 3.82159473 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 3.82155174 |
| 86 | very long-chain fatty acid metabolic process (GO:0000038) | 3.82096145 |
| 87 | COPI coating of Golgi vesicle (GO:0048205) | 3.81022068 |
| 88 | Golgi transport vesicle coating (GO:0048200) | 3.81022068 |
| 89 | ethanol metabolic process (GO:0006067) | 3.80785986 |
| 90 | ketone body metabolic process (GO:1902224) | 3.79186840 |
| 91 | drug catabolic process (GO:0042737) | 3.75667637 |
| 92 | cellular glucuronidation (GO:0052695) | 3.75635991 |
| 93 | cholesterol homeostasis (GO:0042632) | 3.72982999 |
| 94 | L-serine metabolic process (GO:0006563) | 3.72445363 |
| 95 | benzene-containing compound metabolic process (GO:0042537) | 3.70687622 |
| 96 | protein-lipid complex assembly (GO:0065005) | 3.67938583 |
| 97 | cholesterol biosynthetic process (GO:0006695) | 3.66520215 |
| 98 | sterol homeostasis (GO:0055092) | 3.65812894 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.64401724 |
| 100 | organic acid catabolic process (GO:0016054) | 3.64401724 |
| 101 | protein-lipid complex subunit organization (GO:0071825) | 3.58330911 |
| 102 | arginine metabolic process (GO:0006525) | 3.58056009 |
| 103 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.55495686 |
| 104 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.55271698 |
| 105 | low-density lipoprotein particle remodeling (GO:0034374) | 3.54080654 |
| 106 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.52549653 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 3.49431105 |
| 108 | oxaloacetate metabolic process (GO:0006107) | 3.49064106 |
| 109 | regulation of cholesterol metabolic process (GO:0090181) | 3.47358432 |
| 110 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.46835991 |
| 111 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.45384294 |
| 112 | blood coagulation, intrinsic pathway (GO:0007597) | 3.42702491 |
| 113 | plasma lipoprotein particle organization (GO:0071827) | 3.41614365 |
| 114 | cytolysis (GO:0019835) | 3.40570365 |
| 115 | NAD biosynthetic process (GO:0009435) | 3.40534637 |
| 116 | fibrinolysis (GO:0042730) | 3.39519752 |
| 117 | epoxygenase P450 pathway (GO:0019373) | 3.39246810 |
| 118 | diacylglycerol metabolic process (GO:0046339) | 3.36224403 |
| 119 | intestinal absorption (GO:0050892) | 3.32270832 |
| 120 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.27326429 |
| 121 | protein retention in ER lumen (GO:0006621) | 3.25146146 |
| 122 | tricarboxylic acid metabolic process (GO:0072350) | 3.22100434 |
| 123 | positive regulation of extracellular matrix organization (GO:1903055) | 3.19363595 |
| 124 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.14594824 |
| 125 | 4-hydroxyproline metabolic process (GO:0019471) | 3.10077034 |
| 126 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.09043955 |
| 127 | negative regulation of lipid transport (GO:0032369) | 3.08690127 |
| 128 | glucose 6-phosphate metabolic process (GO:0051156) | 2.96685897 |
| 129 | basement membrane organization (GO:0071711) | 2.96678961 |
| 130 | negative regulation of lipase activity (GO:0060192) | 2.95773447 |
| 131 | neutral lipid catabolic process (GO:0046461) | 2.95464019 |
| 132 | acylglycerol catabolic process (GO:0046464) | 2.95464019 |
| 133 | fatty acid homeostasis (GO:0055089) | 2.94683605 |
| 134 | negative regulation of blood coagulation (GO:0030195) | 2.94298676 |
| 135 | negative regulation of hemostasis (GO:1900047) | 2.94298676 |
| 136 | acute-phase response (GO:0006953) | 2.91828013 |
| 137 | lipoprotein metabolic process (GO:0042157) | 2.86161437 |
| 138 | positive regulation of steroid metabolic process (GO:0045940) | 2.85817522 |
| 139 | positive regulation of lipid catabolic process (GO:0050996) | 2.84877061 |
| 140 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.84401590 |
| 141 | monosaccharide biosynthetic process (GO:0046364) | 2.74865714 |
| 142 | primary alcohol catabolic process (GO:0034310) | 2.74434207 |
| 143 | gluconeogenesis (GO:0006094) | 2.72671812 |
| 144 | regulation of extracellular matrix organization (GO:1903053) | 2.68429332 |
| 145 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.67084997 |
| 146 | lung epithelium development (GO:0060428) | 2.67052983 |
| 147 | positive regulation of blood coagulation (GO:0030194) | 2.67014912 |
| 148 | positive regulation of hemostasis (GO:1900048) | 2.67014912 |
| 149 | hexose biosynthetic process (GO:0019319) | 2.66956818 |
| 150 | sexual reproduction (GO:0019953) | 2.65628138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.85658567 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.61986492 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.06623797 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.03263246 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24548156 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.74289112 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.43316907 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01519888 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.78449603 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.09870356 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.57337139 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.44540477 |
| 13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09019423 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00479981 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8153285 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98931242 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88893796 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81124324 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76273831 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72282341 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69892586 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 1.69483710 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67231133 |
| 24 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.63586738 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60642773 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59992431 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58831249 |
| 28 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.54008836 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53400867 |
| 30 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.48138989 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46999613 |
| 32 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46801571 |
| 33 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.45802188 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45615178 |
| 35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44647334 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43158619 |
| 37 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.41133233 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40659047 |
| 39 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.39615348 |
| 40 | KDM2B_26808549_Chip-Seq_K562_Human | 1.37857743 |
| 41 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35910150 |
| 42 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.35706622 |
| 43 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34887276 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33394233 |
| 45 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.33147141 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31413602 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30615994 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29509466 |
| 49 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28888468 |
| 50 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27829852 |
| 51 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.27804764 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23397574 |
| 53 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23275490 |
| 54 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23058245 |
| 55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20970612 |
| 56 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17398557 |
| 57 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17309818 |
| 58 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15764210 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14178648 |
| 60 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.14043239 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12082722 |
| 62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11979893 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11916584 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11825376 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11509279 |
| 66 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11423593 |
| 67 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11223075 |
| 68 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10238980 |
| 69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09694515 |
| 70 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08907954 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08058400 |
| 72 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06721650 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06445452 |
| 74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06308441 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05429392 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02629455 |
| 77 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02450574 |
| 78 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02411644 |
| 79 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01376251 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99967413 |
| 81 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99498478 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99334272 |
| 83 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98907657 |
| 84 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98859443 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96315391 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96097730 |
| 87 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.95410232 |
| 88 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91747373 |
| 89 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.90948553 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90937710 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87893440 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87440610 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83466513 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82312457 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75670756 |
| 96 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75501434 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75456401 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75158708 |
| 99 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.73435896 |
| 100 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70869401 |
| 101 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69977937 |
| 102 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.68568897 |
| 103 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.68471066 |
| 104 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.66980064 |
| 105 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.65941202 |
| 106 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.65359131 |
| 107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.62949849 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.61206815 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.61185317 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.59600383 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.56553659 |
| 112 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.56020482 |
| 113 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.55431146 |
| 114 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55368405 |
| 115 | SA1_27219007_Chip-Seq_Bcells_Human | 0.54973744 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.54855900 |
| 117 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.54675971 |
| 118 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.54633285 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54618772 |
| 120 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.54511223 |
| 121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53467464 |
| 122 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.53298080 |
| 123 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.53117500 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52850742 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52742807 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.52154785 |
| 127 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.51739700 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.51499200 |
| 129 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51194159 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.50978788 |
| 131 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.50876438 |
| 132 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.50743213 |
| 133 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.50662261 |
| 134 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.50481590 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.49472587 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.49363590 |
| 137 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.49168373 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.49051043 |
| 139 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.48831486 |
| 140 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48552195 |
| 141 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.48427251 |
| 142 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.48198290 |
| 143 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.48173960 |
| 144 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.47789430 |
| 145 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.47594462 |
| 146 | P68_20966046_ChIP-Seq_HELA_Human | 0.46804790 |
| 147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.46696234 |
| 148 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.45552041 |
| 149 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.45286601 |
| 150 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.44821425 |
| 151 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.44416686 |
| 152 | P300_27268052_Chip-Seq_Bcells_Human | 0.44195596 |
| 153 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44041470 |
| 154 | NCOR_22424771_ChIP-Seq_293T_Human | 0.43895363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.99132357 |
| 2 | MP0005360_urolithiasis | 7.23672565 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.27342940 |
| 4 | MP0005365_abnormal_bile_salt | 5.94052850 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.00807655 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.58790411 |
| 7 | MP0009840_abnormal_foam_cell | 3.68844980 |
| 8 | MP0003252_abnormal_bile_duct | 3.56825215 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.31657442 |
| 10 | MP0005083_abnormal_biliary_tract | 3.17436950 |
| 11 | MP0003195_calcinosis | 2.97032277 |
| 12 | MP0005332_abnormal_amino_acid | 2.92976369 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.70091129 |
| 14 | * MP0002118_abnormal_lipid_homeostasis | 2.21904917 |
| 15 | MP0000566_synostosis | 2.18099567 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.16984395 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.14096293 |
| 18 | * MP0000609_abnormal_liver_physiology | 1.99132606 |
| 19 | MP0005451_abnormal_body_composition | 1.94753181 |
| 20 | MP0002089_abnormal_postnatal_growth/wei | 1.93742500 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.80323920 |
| 22 | MP0000678_abnormal_parathyroid_gland | 1.71441324 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.66377815 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65223732 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.65160322 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.65005369 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.64924361 |
| 28 | MP0003868_abnormal_feces_composition | 1.64535273 |
| 29 | MP0005409_darkened_coat_color | 1.61794643 |
| 30 | MP0001764_abnormal_homeostasis | 1.56908455 |
| 31 | MP0005410_abnormal_fertilization | 1.45239187 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.44059319 |
| 33 | MP0000003_abnormal_adipose_tissue | 1.41020214 |
| 34 | MP0005375_adipose_tissue_phenotype | 1.40921920 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.39211545 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.38995190 |
| 37 | MP0001849_ear_inflammation | 1.37765254 |
| 38 | MP0002249_abnormal_larynx_morphology | 1.34565720 |
| 39 | MP0003329_amyloid_beta_deposits | 1.34450491 |
| 40 | MP0003690_abnormal_glial_cell | 1.33741112 |
| 41 | MP0000604_amyloidosis | 1.31550088 |
| 42 | MP0005257_abnormal_intraocular_pressure | 1.29691869 |
| 43 | MP0004272_abnormal_basement_membrane | 1.27275214 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.26874227 |
| 45 | MP0000920_abnormal_myelination | 1.24913594 |
| 46 | MP0003879_abnormal_hair_cell | 1.21669414 |
| 47 | MP0003186_abnormal_redox_activity | 1.21432261 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.21076261 |
| 49 | MP0003011_delayed_dark_adaptation | 1.18238693 |
| 50 | MP0004858_abnormal_nervous_system | 1.17671106 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.16067726 |
| 52 | MP0009697_abnormal_copulation | 1.12912927 |
| 53 | MP0001915_intracranial_hemorrhage | 1.12542401 |
| 54 | MP0005647_abnormal_sex_gland | 1.04241056 |
| 55 | MP0004233_abnormal_muscle_weight | 1.02848472 |
| 56 | MP0003123_paternal_imprinting | 1.01337129 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.01315959 |
| 58 | * MP0000598_abnormal_liver_morphology | 1.00089369 |
| 59 | MP0000751_myopathy | 0.94640516 |
| 60 | MP0001661_extended_life_span | 0.92484732 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 0.91816643 |
| 62 | MP0001348_abnormal_lacrimal_gland | 0.91686709 |
| 63 | MP0005408_hypopigmentation | 0.90659922 |
| 64 | MP0000858_altered_metastatic_potential | 0.89374072 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 0.88833081 |
| 66 | MP0000639_abnormal_adrenal_gland | 0.84215441 |
| 67 | MP0005501_abnormal_skin_physiology | 0.82796430 |
| 68 | MP0005330_cardiomyopathy | 0.82169948 |
| 69 | MP0009763_increased_sensitivity_to | 0.82050592 |
| 70 | MP0009115_abnormal_fat_cell | 0.81663696 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.81058779 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.79723011 |
| 73 | * MP0009642_abnormal_blood_homeostasis | 0.78355181 |
| 74 | MP0005266_abnormal_metabolism | 0.78285670 |
| 75 | MP0002971_abnormal_brown_adipose | 0.78281611 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.75921499 |
| 77 | MP0004142_abnormal_muscle_tone | 0.75677629 |
| 78 | MP0009764_decreased_sensitivity_to | 0.74928932 |
| 79 | MP0005023_abnormal_wound_healing | 0.72673149 |
| 80 | MP0000579_abnormal_nail_morphology | 0.72452802 |
| 81 | MP0004381_abnormal_hair_follicle | 0.72182302 |
| 82 | MP0001730_embryonic_growth_arrest | 0.71048251 |
| 83 | MP0009384_cardiac_valve_regurgitation | 0.70504729 |
| 84 | MP0003718_maternal_effect | 0.70194449 |
| 85 | MP0008469_abnormal_protein_level | 0.69343408 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 0.68678526 |
| 87 | MP0010630_abnormal_cardiac_muscle | 0.68661966 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.67700373 |
| 89 | MP0002822_catalepsy | 0.66075578 |
| 90 | MP0005535_abnormal_body_temperature | 0.63741767 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.62746687 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.62688602 |
| 93 | MP0006138_congestive_heart_failure | 0.62632639 |
| 94 | MP0004130_abnormal_muscle_cell | 0.62421139 |
| 95 | MP0005334_abnormal_fat_pad | 0.61759464 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.58908520 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.58435131 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.57936198 |
| 99 | MP0003878_abnormal_ear_physiology | 0.57936198 |
| 100 | MP0004087_abnormal_muscle_fiber | 0.57923337 |
| 101 | MP0004043_abnormal_pH_regulation | 0.57741022 |
| 102 | MP0003091_abnormal_cell_migration | 0.56267609 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.56264652 |
| 104 | MP0005448_abnormal_energy_balance | 0.56177870 |
| 105 | MP0008874_decreased_physiological_sensi | 0.56018720 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.55333776 |
| 107 | MP0005670_abnormal_white_adipose | 0.54707997 |
| 108 | MP0005395_other_phenotype | 0.53770265 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.53769525 |
| 110 | MP0001881_abnormal_mammary_gland | 0.52445654 |
| 111 | MP0003115_abnormal_respiratory_system | 0.52253696 |
| 112 | MP0006082_CNS_inflammation | 0.50605189 |
| 113 | MP0000462_abnormal_digestive_system | 0.50541429 |
| 114 | MP0002254_reproductive_system_inflammat | 0.50473527 |
| 115 | MP0004885_abnormal_endolymph | 0.49058446 |
| 116 | MP0003959_abnormal_lean_body | 0.48493495 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.48318433 |
| 118 | MP0003632_abnormal_nervous_system | 0.48040792 |
| 119 | MP0001756_abnormal_urination | 0.47134146 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.47048483 |
| 121 | MP0008873_increased_physiological_sensi | 0.46025076 |
| 122 | MP0002796_impaired_skin_barrier | 0.45648726 |
| 123 | MP0005075_abnormal_melanosome_morpholog | 0.45604455 |
| 124 | MP0003075_altered_response_to | 0.45170727 |
| 125 | MP0002229_neurodegeneration | 0.42533125 |
| 126 | MP0008260_abnormal_autophagy | 0.41581304 |
| 127 | MP0008872_abnormal_physiological_respon | 0.41552140 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.39908982 |
| 129 | MP0003953_abnormal_hormone_level | 0.39867186 |
| 130 | MP0004147_increased_porphyrin_level | 0.39027184 |
| 131 | MP0003453_abnormal_keratinocyte_physiol | 0.38162594 |
| 132 | MP0003634_abnormal_glial_cell | 0.37132980 |
| 133 | MP0003631_nervous_system_phenotype | 0.36153783 |
| 134 | MP0000467_abnormal_esophagus_morphology | 0.34803189 |
| 135 | MP0003633_abnormal_nervous_system | 0.34779839 |
| 136 | MP0003705_abnormal_hypodermis_morpholog | 0.33979060 |
| 137 | MP0002269_muscular_atrophy | 0.33557976 |
| 138 | MP0002132_abnormal_respiratory_system | 0.33241733 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.32562008 |
| 140 | MP0001324_abnormal_eye_pigmentation | 0.31804588 |
| 141 | MP0003172_abnormal_lysosome_physiology | 0.31685533 |
| 142 | MP0002970_abnormal_white_adipose | 0.28115509 |
| 143 | MP0010368_abnormal_lymphatic_system | 0.28048681 |
| 144 | MP0000747_muscle_weakness | 0.26387644 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.25973883 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.25857604 |
| 147 | MP0009672_abnormal_birth_weight | 0.25212812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.32060777 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.10871949 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.56209441 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.08575067 |
| 5 | Xanthomatosis (HP:0000991) | 5.94915818 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.93357428 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.83913474 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.31541603 |
| 9 | Hyperglycinemia (HP:0002154) | 4.47794734 |
| 10 | Complement deficiency (HP:0004431) | 4.36139834 |
| 11 | Hyperammonemia (HP:0001987) | 4.31761807 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.27267414 |
| 13 | Ketosis (HP:0001946) | 4.22509877 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 4.20404093 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.20404093 |
| 16 | Epidermoid cyst (HP:0200040) | 4.15247584 |
| 17 | Joint hemorrhage (HP:0005261) | 4.05244364 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.02040407 |
| 19 | Fat malabsorption (HP:0002630) | 3.99710904 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.94645119 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.93693631 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.93213551 |
| 23 | Hyperglycinuria (HP:0003108) | 3.90609985 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.79415369 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.61075329 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.47790021 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.41261188 |
| 28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33289038 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.25508376 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.18532158 |
| 31 | Steatorrhea (HP:0002570) | 3.15459777 |
| 32 | Abnormality of the Achilles tendon (HP:0005109) | 3.14702040 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.14447917 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.11332047 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.08920390 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.05820935 |
| 37 | Abnormality of complement system (HP:0005339) | 3.05075213 |
| 38 | Ketoacidosis (HP:0001993) | 3.02695380 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.01741752 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.01397135 |
| 41 | Reticulocytosis (HP:0001923) | 3.00264535 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 2.98614187 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.78331948 |
| 44 | Spontaneous abortion (HP:0005268) | 2.71047595 |
| 45 | Achilles tendon contracture (HP:0001771) | 2.70450528 |
| 46 | Metabolic acidosis (HP:0001942) | 2.68431028 |
| 47 | Lethargy (HP:0001254) | 2.68003839 |
| 48 | Acanthocytosis (HP:0001927) | 2.67779433 |
| 49 | Vertebral compression fractures (HP:0002953) | 2.61934709 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.60979280 |
| 51 | Myocardial infarction (HP:0001658) | 2.60079634 |
| 52 | Abnormality of carpal bone ossification (HP:0006257) | 2.58871008 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57178482 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.57178482 |
| 55 | Irritability (HP:0000737) | 2.54845416 |
| 56 | Vascular calcification (HP:0004934) | 2.53831547 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.52942691 |
| 58 | Flat acetabular roof (HP:0003180) | 2.51814178 |
| 59 | Opisthotonus (HP:0002179) | 2.51153335 |
| 60 | Spastic paraparesis (HP:0002313) | 2.44628674 |
| 61 | Cholecystitis (HP:0001082) | 2.44277943 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.44277943 |
| 63 | Gout (HP:0001997) | 2.43967936 |
| 64 | Distal upper limb amyotrophy (HP:0007149) | 2.43430812 |
| 65 | Upper limb amyotrophy (HP:0009129) | 2.43430812 |
| 66 | Ulnar bowing (HP:0003031) | 2.41246761 |
| 67 | Brushfield spots (HP:0001088) | 2.39138830 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.38558453 |
| 69 | Skin nodule (HP:0200036) | 2.37281121 |
| 70 | Malnutrition (HP:0004395) | 2.37255984 |
| 71 | Cerebral edema (HP:0002181) | 2.36792520 |
| 72 | Neurofibrillary tangles (HP:0002185) | 2.35774604 |
| 73 | Hypertriglyceridemia (HP:0002155) | 2.34102384 |
| 74 | Amyloidosis (HP:0011034) | 2.32707137 |
| 75 | Purpura (HP:0000979) | 2.32642211 |
| 76 | Cholelithiasis (HP:0001081) | 2.31833703 |
| 77 | Stridor (HP:0010307) | 2.26646878 |
| 78 | Abnormal ossification of hand bones (HP:0005921) | 2.17349184 |
| 79 | Hyperacusis (HP:0010780) | 2.17338073 |
| 80 | Back pain (HP:0003418) | 2.16323686 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.15272995 |
| 82 | Turricephaly (HP:0000262) | 2.14940938 |
| 83 | Hepatocellular carcinoma (HP:0001402) | 2.14559646 |
| 84 | Mitral stenosis (HP:0001718) | 2.14202622 |
| 85 | Vomiting (HP:0002013) | 2.13499651 |
| 86 | Hypoglycemic seizures (HP:0002173) | 2.10742705 |
| 87 | Spastic diplegia (HP:0001264) | 2.09404749 |
| 88 | Hypophosphatemic rickets (HP:0004912) | 2.09013495 |
| 89 | Premature rupture of membranes (HP:0001788) | 2.07342426 |
| 90 | Rickets (HP:0002748) | 2.07167534 |
| 91 | Abnormality of glycolysis (HP:0004366) | 2.03891479 |
| 92 | Increased serum pyruvate (HP:0003542) | 2.03891479 |
| 93 | Cerebral aneurysm (HP:0004944) | 2.03184980 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 2.01498721 |
| 95 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00949373 |
| 96 | Neonatal death (HP:0003811) | 2.00285014 |
| 97 | Paraparesis (HP:0002385) | 1.98749042 |
| 98 | Neonatal onset (HP:0003623) | 1.96399886 |
| 99 | Systemic lupus erythematosus (HP:0002725) | 1.95662541 |
| 100 | Hand muscle atrophy (HP:0009130) | 1.94491937 |
| 101 | Abnormality of vitamin metabolism (HP:0100508) | 1.94388371 |
| 102 | Generalized aminoaciduria (HP:0002909) | 1.93805442 |
| 103 | Alkalosis (HP:0001948) | 1.93506756 |
| 104 | Pancreatitis (HP:0001733) | 1.92745438 |
| 105 | Nephritis (HP:0000123) | 1.92114082 |
| 106 | Distal lower limb amyotrophy (HP:0008944) | 1.90348447 |
| 107 | Gingival bleeding (HP:0000225) | 1.88831341 |
| 108 | Biconcave vertebral bodies (HP:0004586) | 1.88748623 |
| 109 | Poikilocytosis (HP:0004447) | 1.88600458 |
| 110 | Acanthosis nigricans (HP:0000956) | 1.87580558 |
| 111 | Polycythemia (HP:0001901) | 1.87089152 |
| 112 | Distal lower limb muscle weakness (HP:0009053) | 1.86246104 |
| 113 | Sensorimotor neuropathy (HP:0007141) | 1.86099650 |
| 114 | Acute hepatic failure (HP:0006554) | 1.85951403 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.85345857 |
| 116 | Late onset (HP:0003584) | 1.83377153 |
| 117 | Abnormal tarsal ossification (HP:0008369) | 1.81656748 |
| 118 | Thin bony cortex (HP:0002753) | 1.80945318 |
| 119 | Enlarged kidneys (HP:0000105) | 1.80150825 |
| 120 | Glomerulonephritis (HP:0000099) | 1.79824066 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.79796609 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.79796609 |
| 123 | Delayed myelination (HP:0012448) | 1.78556539 |
| 124 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78117473 |
| 125 | Cerebral inclusion bodies (HP:0100314) | 1.77886651 |
| 126 | Confusion (HP:0001289) | 1.76621998 |
| 127 | Atelectasis (HP:0100750) | 1.76337963 |
| 128 | Abnormal hand bone ossification (HP:0010660) | 1.76189791 |
| 129 | Abnormality of the acetabulum (HP:0003170) | 1.75737069 |
| 130 | Seborrheic dermatitis (HP:0001051) | 1.75695884 |
| 131 | Increased connective tissue (HP:0009025) | 1.74112237 |
| 132 | Abnormality of iron homeostasis (HP:0011031) | 1.73780261 |
| 133 | Menorrhagia (HP:0000132) | 1.73546997 |
| 134 | Asymmetry of the thorax (HP:0001555) | 1.72333485 |
| 135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72060665 |
| 136 | Glycosuria (HP:0003076) | 1.71047015 |
| 137 | Cervical subluxation (HP:0003308) | 1.70701605 |
| 138 | Increased serum ferritin (HP:0003281) | 1.70083355 |
| 139 | Abnormality of reticulocytes (HP:0004312) | 1.69807866 |
| 140 | Rhabdomyolysis (HP:0003201) | 1.68447902 |
| 141 | Advanced eruption of teeth (HP:0006288) | 1.66919229 |
| 142 | Abnormality of the thoracic spine (HP:0100711) | 1.64297082 |
| 143 | Self-mutilation (HP:0000742) | 1.63679195 |
| 144 | Short nail (HP:0001799) | 1.62544721 |
| 145 | Bronchomalacia (HP:0002780) | 1.61615353 |
| 146 | Focal segmental glomerulosclerosis (HP:0000097) | 1.61332255 |
| 147 | Abnormality of pain sensation (HP:0010832) | 1.60999533 |
| 148 | Impaired pain sensation (HP:0007328) | 1.60999533 |
| 149 | Abnormal delivery (HP:0001787) | 1.60010622 |
| 150 | Growth hormone excess (HP:0000845) | 1.59838749 |
| 151 | Elevated alkaline phosphatase (HP:0003155) | 1.59216851 |
| 152 | Glomerulosclerosis (HP:0000096) | 1.59106795 |
| 153 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.58835452 |
| 154 | Insomnia (HP:0100785) | 1.58567217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.58086222 |
| 2 | ICK | 3.91050428 |
| 3 | MAPK15 | 3.50831309 |
| 4 | SIK1 | 3.35049344 |
| 5 | STK39 | 3.27939431 |
| 6 | SMG1 | 3.00532871 |
| 7 | FGFR4 | 2.97358212 |
| 8 | OXSR1 | 2.78451993 |
| 9 | PINK1 | 2.67886555 |
| 10 | EPHA2 | 2.65652721 |
| 11 | EPHB1 | 2.64366700 |
| 12 | TESK1 | 2.62231331 |
| 13 | RIPK1 | 2.54945616 |
| 14 | EEF2K | 2.50912897 |
| 15 | IRAK3 | 2.45312812 |
| 16 | ERBB4 | 2.36476859 |
| 17 | ERN1 | 2.28557042 |
| 18 | MET | 1.97212263 |
| 19 | CDK12 | 1.96911989 |
| 20 | NME2 | 1.76435307 |
| 21 | PKN1 | 1.74526352 |
| 22 | CDK19 | 1.72863919 |
| 23 | SCYL2 | 1.66655101 |
| 24 | MAP3K11 | 1.64762482 |
| 25 | WNK4 | 1.64642731 |
| 26 | FGFR2 | 1.62154978 |
| 27 | FGR | 1.61132680 |
| 28 | UHMK1 | 1.60559945 |
| 29 | PRPF4B | 1.59271626 |
| 30 | DDR2 | 1.58024531 |
| 31 | TAOK3 | 1.56747904 |
| 32 | MAPK11 | 1.56416895 |
| 33 | INSRR | 1.55202432 |
| 34 | CSNK1G1 | 1.50014631 |
| 35 | MAP3K6 | 1.47075768 |
| 36 | CSNK1G3 | 1.46038572 |
| 37 | PDGFRA | 1.42303824 |
| 38 | KSR2 | 1.38980657 |
| 39 | TYRO3 | 1.34495577 |
| 40 | LMTK2 | 1.33830345 |
| 41 | DYRK1B | 1.32111421 |
| 42 | PBK | 1.29194857 |
| 43 | CSK | 1.29131010 |
| 44 | PRKD3 | 1.25973705 |
| 45 | CAMK2G | 1.25089072 |
| 46 | MST1R | 1.23045438 |
| 47 | CSNK1A1L | 1.20023650 |
| 48 | MAP2K3 | 1.19961055 |
| 49 | LATS2 | 1.17733267 |
| 50 | TAOK2 | 1.15359691 |
| 51 | TTN | 1.12957762 |
| 52 | FGFR3 | 1.12849476 |
| 53 | BCR | 1.11852675 |
| 54 | GSK3A | 1.08932788 |
| 55 | PAK4 | 1.08124824 |
| 56 | CSNK1G2 | 1.03028061 |
| 57 | STK16 | 1.00581466 |
| 58 | MAP3K1 | 0.99041162 |
| 59 | BMX | 0.98411191 |
| 60 | MAP3K3 | 0.96634262 |
| 61 | STK38 | 0.96492132 |
| 62 | EPHA4 | 0.95882390 |
| 63 | PRKAA2 | 0.95806136 |
| 64 | MATK | 0.94887048 |
| 65 | MAP2K4 | 0.93157079 |
| 66 | PRKCZ | 0.88602163 |
| 67 | CAMK2B | 0.86705080 |
| 68 | MAPK4 | 0.85092386 |
| 69 | RET | 0.84213057 |
| 70 | CDK7 | 0.82680668 |
| 71 | ABL2 | 0.82121633 |
| 72 | MAP3K7 | 0.80922808 |
| 73 | PRKG2 | 0.80168087 |
| 74 | DAPK2 | 0.79110031 |
| 75 | SGK223 | 0.78353426 |
| 76 | SGK494 | 0.78353426 |
| 77 | TESK2 | 0.74985371 |
| 78 | PIK3CG | 0.74851493 |
| 79 | MAPKAPK3 | 0.74821910 |
| 80 | MAP3K8 | 0.74687002 |
| 81 | BRAF | 0.73941016 |
| 82 | MAP3K2 | 0.71524407 |
| 83 | PHKG1 | 0.69593331 |
| 84 | PHKG2 | 0.69593331 |
| 85 | JAK2 | 0.68986819 |
| 86 | CDC42BPA | 0.68920688 |
| 87 | PDPK1 | 0.66821045 |
| 88 | PRKAA1 | 0.65924469 |
| 89 | MAP3K10 | 0.64723499 |
| 90 | MAP3K13 | 0.63961205 |
| 91 | PAK2 | 0.62514570 |
| 92 | PRKCQ | 0.61698460 |
| 93 | PRKACG | 0.61659405 |
| 94 | AKT3 | 0.60607236 |
| 95 | TAOK1 | 0.58624368 |
| 96 | CDK4 | 0.58596051 |
| 97 | RPS6KA2 | 0.56927886 |
| 98 | MAP2K2 | 0.56907422 |
| 99 | FLT3 | 0.56040017 |
| 100 | CAMK2D | 0.55449965 |
| 101 | NTRK1 | 0.53861744 |
| 102 | PRKD2 | 0.53852746 |
| 103 | TNIK | 0.53422265 |
| 104 | RAF1 | 0.53316715 |
| 105 | ARAF | 0.52189377 |
| 106 | AKT2 | 0.51668093 |
| 107 | ERBB2 | 0.50175736 |
| 108 | TYK2 | 0.49126659 |
| 109 | RPS6KB2 | 0.48777348 |
| 110 | PTK2 | 0.48306232 |
| 111 | SIK2 | 0.48248982 |
| 112 | DAPK3 | 0.47729081 |
| 113 | TRIB3 | 0.47291833 |
| 114 | ILK | 0.46816840 |
| 115 | PRKD1 | 0.46255101 |
| 116 | PTK6 | 0.46081227 |
| 117 | GRK6 | 0.45350188 |
| 118 | DAPK1 | 0.44284785 |
| 119 | MAPK12 | 0.43993443 |
| 120 | CAMK1D | 0.43057476 |
| 121 | AURKA | 0.42895631 |
| 122 | BRSK1 | 0.42594514 |
| 123 | LIMK1 | 0.42304656 |
| 124 | MAPK7 | 0.41537964 |
| 125 | IRAK2 | 0.41533211 |
| 126 | CAMK2A | 0.41043401 |
| 127 | TBK1 | 0.40206107 |
| 128 | MAP3K9 | 0.39009053 |
| 129 | PAK3 | 0.38863283 |
| 130 | MAP2K1 | 0.36601428 |
| 131 | DYRK2 | 0.36060239 |
| 132 | PIM2 | 0.35696977 |
| 133 | LRRK2 | 0.33576721 |
| 134 | CSF1R | 0.33117370 |
| 135 | EIF2AK1 | 0.32843988 |
| 136 | PAK6 | 0.32755003 |
| 137 | CDK11A | 0.32665922 |
| 138 | CDK8 | 0.30889508 |
| 139 | CAMKK1 | 0.30746980 |
| 140 | PDK1 | 0.29628173 |
| 141 | MTOR | 0.28560756 |
| 142 | CDK15 | 0.28114994 |
| 143 | PRKACB | 0.28055958 |
| 144 | PKN2 | 0.27387847 |
| 145 | EGFR | 0.27318223 |
| 146 | KDR | 0.27131490 |
| 147 | PAK1 | 0.27071482 |
| 148 | CDK9 | 0.26938638 |
| 149 | NEK6 | 0.26794784 |
| 150 | CDK6 | 0.26236037 |
| 151 | MAPKAPK5 | 0.25774493 |
| 152 | PRKACA | 0.25703352 |
| 153 | RPS6KC1 | 0.25583044 |
| 154 | PRKCG | 0.25007686 |
| 155 | IRAK1 | 0.24779179 |
| 156 | MARK2 | 0.22817723 |
| 157 | ABL1 | 0.22230360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.04369433 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.10965984 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.04391571 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93510599 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83437473 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.74973712 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.73391099 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59724681 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50487497 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46621607 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.39519045 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37049904 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.34353174 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.29352572 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26596243 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.12447712 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.11936896 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.09193909 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.07477831 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00961024 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.99804156 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99348270 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.84342512 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.78764291 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74032192 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73880293 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73658766 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63905539 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.63565072 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61931074 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58180822 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56883269 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.55199253 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54050049 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53179289 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.52717332 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51240796 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49868006 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49639557 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44500797 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43200264 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.39821249 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35418822 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.35417082 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34982756 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.34819593 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32049337 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27322932 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26549511 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20413207 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.20166376 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.19337262 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12078038 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10944390 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09614844 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08455340 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04811390 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00687497 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92396200 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.91636821 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86649620 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86031877 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83419084 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.75704154 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75648461 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75543419 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74798587 |
| 68 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70658988 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58520855 |
| 70 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.58022542 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56719743 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52252988 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50402666 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49329715 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47237847 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44366571 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43473978 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39406738 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39014615 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37260805 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37216258 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36439927 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34257693 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32030119 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31666625 |
| 86 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28506409 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.27957888 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27330174 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26159750 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25248744 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25068932 |
| 92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.24755113 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24331505 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23255505 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20763609 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.20628304 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20578324 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19800094 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.19782107 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.18444556 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.17866426 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.16725766 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15910813 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08280676 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03337281 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.02814735 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01991654 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01560496 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.2595472 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | -0.2521286 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2408154 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | -0.2209679 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2146264 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.2047853 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2038355 |
| 116 | Alzheimers disease_Homo sapiens_hsa05010 | -0.2003277 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1862928 |
| 118 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1784122 |
| 119 | Lysosome_Homo sapiens_hsa04142 | -0.1302972 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1238722 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | -0.0909464 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0755507 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0449177 |
| 124 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0274021 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0215334 |

